Lumos Pharma, Inc. (LUMO) Social Stream



Lumos Pharma, Inc. (LUMO): $3.34

0.11 (+3.41%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add LUMO to Watchlist
Sign Up

Industry: Biotech


Ranked

of 507

in industry

LUMOS PHARMA INC (LUMO) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering LUMO.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 5 $35 $17 $27.6 $3.16 773.42%
2022-05-11 5 $35 $17 $25 $3.16 691.14%
2022-08-10 5 $31 $17 $23.5 $3.16 643.67%
2022-11-14 6 $31 $17 $23.5 $3.16 643.67%
2022-12-08 6 $31 $7 $21.833 $3.16 590.92%
2023-01-18 5 $28 $7 $18.6 $3.16 488.61%
2023-03-05 5 $28 $4 $18 $3.16 469.62%

The Trend in the Analyst Price Target


LUMO's average price target has moved down $13.86 over the prior 23 months.

LUMO reports an average of 305.92% for its upside potential over the past 43 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-08-10 6 31 17 23.500 8.31 182.79%
2022-08-10 5 31 17 23.500 8.31 182.79%
2022-11-15 6 31 7 21.833 4.95 341.07%
2022-12-08 6 31 7 21.833 4.20 419.83%
2023-03-05 5 28 4 18.000 3.49 415.76%

LUMO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.4 4 0 1 0 0 5

The Trend in the Broker Recommendations


Over the past 16 months, LUMO's average broker recommendation rating worsened by 0.4.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for LUMO as an investment opportunity.

  • LUMOS PHARMA INC's upside potential (average analyst target price relative to current price) is greater than 748.51% of all US stocks.
  • In terms of how LUMOS PHARMA INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -525.83% of that group.
  • LUMO has a higher number of analysts covering the stock than 262.16% of Healthcare stocks.
  • LUMOS PHARMA INC's average analyst price target is higher than 315.35% of Healthcare stocks.

Stocks similar to LUMOS PHARMA INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CBIO, ADXS, and CPIX.

Is LUMO a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.8001 seconds.